AstraZeneca’s Tagrisso helps lung cancer patients live longer: study
(Corrects Aug. 9 story to show study points to overall survival and not progression free survival...
Read MoreSep 4, 2019
(Corrects Aug. 9 story to show study points to overall survival and not progression free survival...
Read MoreSep 4, 2019
(Reuters) – AstraZeneca Plc said on Wednesday it had received marketing authorization from China’s National Medical Products Administration for its top-selling drug, Tagrisso, to treat adults with a form of lung...
Read MoreSep 4, 2019
ZURICH (Reuters) – Drugmaker Polyphor is hiring new managers and shifting focus after a trial of its top antibiotic hopeful proved too dangerous to continue, the Swiss company said on Wednesday. Chief Financial Officer...
Read MoreSep 3, 2019
By Jonathan Stempel (Reuters) – A U.S. judge on Tuesday rejected efforts by major...
Read MoreSep 3, 2019
(Reuters) – Novartis AG’s gene therapy for blindness, Luxturna, is recommended for use on England’s public health service, the country’s healthcare cost-effectiveness watchdog NICE said on Tuesday....
Read MoreSep 3, 2019
By Lisa Rapaport (Reuters Health) – Exercise can do more to lower the risk of premature death for patients with cardiovascular disease than for healthy people, a new study suggests. Healthy people did have a lower chance...
Read MoreSep 3, 2019
By Will Boggs MD NEW YORK (Reuters Health) – Women with a high risk of developing breast cancer can lower that risk by taking certain medications, according to updated recommendations from the US Preventive Services Task...
Read MoreSep 3, 2019
By Lisa Rapaport (Reuters Health) – A growing number of extremely tiny newborns are being sent home from the hospital with human milk for feedings when their mothers don’t produce enough milk to meet their...
Read MoreSep 3, 2019
By Linda Carroll (Reuters Health) – Consumption of soft drinks, whether they’re sweetened with sugar or artificial sweeteners, may raise the risk of premature death, new research suggests. In a study that followed...
Read MoreSep 3, 2019
LONDON (Reuters) – Cancer has overtaken heart disease as the leading cause of death in...
Read MoreSep 3, 2019
By John Miller ZURICH (Reuters) – Swiss drugmakers Novartis and Lonza separately deepened their push into so-called biosimilars, betting cheaper copies of name-brand drugs will make headway among cost-conscious insurers...
Read MoreSep 3, 2019
BEIJING (Reuters) – China and the United States have only “limited” cooperation...
Read MoreSep 2, 2019
By Linda Carroll (Reuters Health) – Tiny bits of plastic may be getting into our bodies via the air we breathe and the food we eat, a new study suggests. Researchers who examined stool samples from eight people from...
Read MoreSep 2, 2019
By Linda Carroll (Reuters Health) – Over the past decade, the number of children and teens in the U.S diagnosed with tuberculosis has decreased by nearly half, according to a new study. But that good news doesn’t...
Read MoreSep 2, 2019
By Gene Emery A new study offers some advice for doctors poking around the heart to reopen a clogged artery that has caused one type of heart attack: Come back again to finish the job. The study found that when doctors also open...
Read MoreSep 2, 2019
(Reuters) – The United States recorded 19 new measles cases last week, taking the total...
Read MoreSep 2, 2019
BRNO (Reuters) – When a helicopter rushed an unconscious Czech woman who had suffered a severe stroke to hospital in April, her chances of survival were slim – and those of the fetus she had carried in her womb for...
Read MoreSep 2, 2019
BEIJING (Reuters) – A city in southern China is selling a limited quantity of pork at discounted prices to help consumers cope with soaring prices, as the world’s top pork-eating nation deals with a meat shortage...
Read MoreSep 2, 2019
By Vishwadha Chander (Reuters Health) – For obese diabetics in a large U.S. study, weight-loss surgery was linked with a significant reduction in long-term rates of major cardiovascular problems. The study doesn’t...
Read MoreAug 30, 2019
By Manas Mishra and Manojna Maddipatla (Reuters) – The U.S. patent office will review...
Read More